Boston Family Office’s CRISPR Therapeutics CRSP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
|
|||||
|
2025
Q1 | $332K | Hold |
|
|||||
|
2024
Q4 | $384K | Hold |
|
|||||
|
2024
Q3 | $459K | Buy |
|
|||||
|
2024
Q2 | $516K | Hold |
|
|||||
|
2024
Q1 | $651K | Hold |
|
|||||
|
2023
Q4 | $598K | Hold |
|
|||||
|
2023
Q3 | $433K | Hold |
|
|||||
|
2023
Q2 | $536K | Hold |
|
|||||
|
2023
Q1 | $432K | Hold |
|
|||||
|
2022
Q4 | $388K | Hold |
|
|||||
|
2022
Q3 | $624K | Hold |
|
|||||
|
2022
Q2 | $580K | Hold |
|
|||||
|
2022
Q1 | $599K | Hold |
|
|||||
|
2021
Q4 | $724K | Hold |
|
|||||
|
2021
Q3 | $1.07M | Hold |
|
|||||
|
2021
Q2 | $1.55M | Hold |
|
|||||
|
2021
Q1 | $1.16M | Sell |
|
|||||
|
2020
Q4 | $1.58M | Hold |
|
|||||
|
2020
Q3 | $861K | Hold |
|
|||||
|
2020
Q2 | $757K | Hold |
|
|||||
|
2020
Q1 | $437K | Hold |
|
|||||
|
2019
Q4 | $627K | Sell |
|
|||||
|
2019
Q3 | $426K | Hold |
|
|||||
|
2019
Q2 | $490K | Hold |
|
|||||
|
2019
Q1 | $371K | Hold |
|
|||||
|
2018
Q4 | $297K | Sell |
|
|||||
|
2018
Q3 | $466K | Buy |
|
|||||
|
2018
Q2 | $611K | Buy |
|
|||||
|
2018
Q1 | $457K | Buy |
|